Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 24, 2017
Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulinsArun Sanyal, Kenneth Cusi, Mark L Hartman, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2015
Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLDFernando Bril, John J Sninsky, Arthur M Baca, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery diseaseJacob J Gries, Jeffrey V Lazarus, Paul N Brennan, et al.
Gastroenterology|August 21, 2021
Preparing for the NASH Epidemic: A Call to ActionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
Diabetes Care|July 27, 2021
Preparing for the NASH Epidemic: A Call to ActionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
Diabetes, Obesity & Metabolism|April 29, 2026
High Prevalence of Metabolic Dysfunction-Associated Steatohepatitis With Significant Fibrosis in Primary Care and Endocrinology ClinicsSrilaxmi Kalavalapalli, Eddison Godinez Leiva, Andrea Ortiz Rocha, et al.
Obesity (Silver Spring, Md.)|August 8, 2021
Preparing for the NASH epidemic: A call to actionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2026
Severity of MASH Activity by Iron-Corrected MRI Predicts Insulin Resistance and Cardiometabolic Risk in Type 2 DiabetesAndrea Ortiz Rocha, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Obesity (Silver Spring, Md.)|September 24, 2024
Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screenAnu Sharma, Eddison Godina Leiva, Srilaxmi Kalavalapalli, et al.
European Journal of Endocrinology|February 19, 2021
Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based studyMaría Teresa Julián, Guillem Pera, Berta Soldevila, et al.
Pageof 19